Hemex Health Inc.
Portland, OR
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 4640 S Macadam Ave #200a, Portland, OR 97239, USA
- Website
- hemexhealth.com
- Founded
- 2015
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase 1 diagnostics to enable malaria and neglected tropical diseases | National Institute of Allergy and Infectious Diseases (NIH) | $225,000 |
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Case Western Reserve University | R01CA306044 | $142,428 |
Similar vendors
About the company
Hemex Health Inc. is a for-profit corporate entity specializing in developing innovative point-of-care diagnostic technologies, with a primary focus on medical device development for complex medical conditions. Registered in SAM.gov since 2016, the company appears to concentrate on creating portable, microchip-based diagnostic platforms that enable rapid testing and screening for various medical disorders, particularly in low-resource settings. The company's diagnostic technologies are designed to provide quick, affordable, and precise medical testing solutions that can be used in diverse environments, from rural clinics to battlefield medical settings.
Hemex Health Inc. has been awarded multiple federal grants from civilian agencies, predominantly from the National Heart Lung and Blood Institute, National Institute of Neurological Disorders and Stroke, and National Institute of Allergy and Infectious Diseases. Their grant-funded projects consistently focus on developing advanced diagnostic technologies for specific medical challenges, such as a point-of-care device for traumatic brain injury biomarker detection, a rapid hemoglobin-oxygen dissociation assay for sickle cell disease screening, a multi-spectral imaging system for newborn hemoglobin variant testing, and a point-of-care diagnostic for malaria. These projects share common characteristics: they aim to create portable, affordable diagnostic platforms that can perform complex medical tests quickly and accurately, with a particular emphasis on improving medical diagnostics in low-resource or remote settings. The technologies often involve sophisticated micro-engineering methods, optical spectroscopy, and advanced data analysis techniques to provide precise, quantitative medical information.
Quick answers
Is Hemex Health Inc. registered in SAM.gov?
Yes. Hemex Health Inc.'s SAM.gov registration is active through December 29, 2026.
What is Hemex Health Inc.'s CAGE code?
Hemex Health Inc.'s CAGE code is 7PAA4, and its Unique Entity ID (UEI) is LSJ7WFKBJWW4.
What is Hemex Health Inc.'s most recent federal award?
Hemex Health Inc.'s most recent federal grant award is Using an inclined plane system to triage TBI patients project summary: traumatic brain injury (TBI), such as that… (R43NS135862), from National Institute of Neurological Disorders and Stroke (NIH), on September 16, 2024.
On GovTribe
See Hemex Health Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors